Waters Corporation logo

Waters Corporation (WAT)

Market Open
5 Dec, 16:43
NYSE NYSE
$
395. 02
-1.35
-0.34%
$
24.02B Market Cap
29.16 P/E Ratio
0% Div Yield
106,711 Volume
11.69 Eps
$ 396.37
Previous Close
Day Range
392.79 399.85
Year Range
275.05 423.56
Want to track WAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days
Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?

Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Zacks | 23 hours ago
Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Waters Corporation ( WAT ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Udit Batra - President, CEO & Director Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division Okay. Thank you, everybody.

Seekingalpha | 2 weeks ago
Waters Q3 Earnings Surpass Estimates, Revenue Increase Y/Y

Waters Q3 Earnings Surpass Estimates, Revenue Increase Y/Y

WAT posts strong Q3 results with 16% earnings growth and higher sales, lifting its full-year outlook for 2025.

Zacks | 4 weeks ago
Waters Corporation (WAT) Q3 2025 Earnings Call Transcript

Waters Corporation (WAT) Q3 2025 Earnings Call Transcript

Waters Corporation ( WAT ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President, CEO & Director Amol Chaubal - Senior VP & CFO Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Jack Meehan - Nephron Research LLC Puneet Souda - Leerink Partners LLC, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Douglas Schenkel - Wolfe Research, LLC Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Operator Welcome to the Waters Corporation's Third Quarter 2025 Financial Results Conference Call.

Seekingalpha | 1 month ago
Waters (WAT) Tops Q3 Earnings and Revenue Estimates

Waters (WAT) Tops Q3 Earnings and Revenue Estimates

Waters (WAT) came out with quarterly earnings of $3.4 per share, beating the Zacks Consensus Estimate of $3.21 per share. This compares to earnings of $2.93 per share a year ago.

Zacks | 1 month ago
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth

Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 month ago
Waters Corporation (WAT) Q2 2025 Earnings Call Transcript

Waters Corporation (WAT) Q2 2025 Earnings Call Transcript

Waters Corporation (NYSE:WAT ) Q2 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Amol Chaubal - Senior VP & CFO Caspar Tudor - Head of Investor Relations Udit Batra - President, CEO & Director Conference Call Participants Catherine Walden Ramsey Schulte - Robert W. Baird & Co. Incorporated, Research Division Daniel Gregory Brennan - TD Cowen, Research Division Jack Meehan - Nephron Research LLC Puneet Souda - Leerink Partners LLC, Research Division Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division Sung Ji Nam - Scotiabank Global Banking and Markets, Research Division Tycho W.

Seekingalpha | 4 months ago
Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates

Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates

Waters (WAT) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.63 per share a year ago.

Zacks | 4 months ago
Why Waters (WAT) is a Top Growth Stock for the Long-Term

Why Waters (WAT) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago
Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 4 months ago
Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 4 months ago
Waters and BD Biosciences & Diagnostic Solutions announce $17.5B merger

Waters and BD Biosciences & Diagnostic Solutions announce $17.5B merger

Waters Corp (NYSE:WAT) shares fell more than 12% after it announced a business combination deal with BD Biosciences & Diagnostic Solutions (NYSE:BDX), forming a new life sciences and diagnostics leader focused on high-volume, regulated testing markets. The transaction, structured as a Reverse Morris Trust and valued at approximately $17.5 billion, is expected to significantly expand Waters' market reach and strengthen its position in key adjacent sectors.

Proactiveinvestors | 4 months ago
Loading...
Load More